ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,762Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 3001

$539K Total Retail Price of All Prescriptions

Rank: 554 out of 3001

290 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,238 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
FUROSEMIDE 501 397 1 6
OMEPRAZOLE 479 377 2 4
LEVOTHYROXINE SODIUM 445 354 3 3
HYDROCODONE-ACETAMINOPHEN 255 221 S3 4 7
SIMVASTATIN 253 143 5 1
LISINOPRIL 244 205 6 2
POTASSIUM CHLORIDE 244 230 6 15
METOPROLOL TARTRATE 217 187 8 8
RISPERIDONE 203 119 9 63
CITALOPRAM HBR 202 142 10 16
FENTANYL 176 175 S2 11 76
POLYETHYLENE GLYCOL 3350 160 101 12 55
LACTULOSE 157 79 13 116
SERTRALINE HCL 156 121 14 20
TRAZODONE HCL 156 102 14 37
ALBUTEROL SULFATE 146 130 16 99
WARFARIN SODIUM 135 79 17 12
GABAPENTIN 133 112 18 14
QUETIAPINE FUMARATE 132 83 19 66
OLANZAPINE 118 81 20 106
DIVALPROEX SODIUM ER 113 0 21 142
AMLODIPINE BESYLATE 109 107 22 5
NAMENDA 108 102 23 40
METFORMIN HCL 107 81 24 9
CYMBALTA 105 91 25 53
DILANTIN 104 85 26 225
LEVETIRACETAM 102 53 27 112
PHENYTOIN SODIUM EXTENDED 99 64 28 126
CLOPIDOGREL 96 87 29 28
METHYLPHENIDATE HCL 92 82 30 401
CEPHALEXIN 90 78 31 86
ISOSORBIDE MONONITRATE ER 90 74 31 45
OXYCODONE-ACETAMINOPHEN 89 89 S2 33 32
VENLAFAXINE HCL ER 83 72 34 103
JANTOVEN 83 83 34 110
GLIMEPIRIDE 82 61 36 31
METOPROLOL SUCCINATE 82 82 36 19
DONEPEZIL HCL 81 81 38 27
ATORVASTATIN CALCIUM 77 71 39 11
ALENDRONATE SODIUM 76 16 40 26
LANTUS 76 38 40 47
DIGOXIN 73 61 42 65
HYDROCHLOROTHIAZIDE 72 60 43 10
CARBIDOPA-LEVODOPA 71 71 44 97
ATENOLOL 71 66 44 18
BENZTROPINE MESYLATE 70 16 R 46 127
TRAMADOL HCL 68 68 47 17
OXCARBAZEPINE 68 41 47 217
NOVOLOG 66 48 49 94
CARVEDILOL 62 50 50 25
SEROQUEL 62 41 50 146
PLAVIX 56 51 52 46
HALOPERIDOL 53 23 53 147
IBUPROFEN 53 38 53 74
NYSTATIN 52 47 55 149
AZITHROMYCIN 52 52 55 36
OXYBUTYNIN CHLORIDE 51 51 57 120
DIOVAN 51 51 57 50
CARBAMAZEPINE XR 50 17 59 255
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.